In patients with type 2 diabetes who are maximized on metformin with HbA1C above 7%, are GLP-1 agonists more effective than sulfonylureas for lowering HbA1C?

Bernard Noveloso, Trina Hara, Jamuna Manoharan, James Putman

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)15
Number of pages1
JournalEvidence-Based Practice
Volume20
Issue number2
StatePublished - Feb 2017

Fingerprint

Dive into the research topics of 'In patients with type 2 diabetes who are maximized on metformin with HbA1C above 7%, are GLP-1 agonists more effective than sulfonylureas for lowering HbA1C?'. Together they form a unique fingerprint.

Cite this